Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ulecaciclib by Aucentra Therapeutics for Cervical Cancer: Likelihood of Approval
Ulecaciclib is under clinical development by Aucentra Therapeutics and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...
Data Insights
Ulecaciclib by Aucentra Therapeutics for Liver Cancer: Likelihood of Approval
Ulecaciclib is under clinical development by Aucentra Therapeutics and currently in Phase II for Liver Cancer. According to GlobalData, Phase...